How to Help Your Patients Find Jublia in Stock: A Provider's Guide

Prescribing Jublia (efinaconazole 10% topical solution) is the easy part. The hard part — for many patients — is actually getting it filled. Whether the barrier is insurance coverage, cost, or pharmacy availability, a significant number of patients prescribed Jublia never complete treatment because they can't reliably access the medication. This guide gives prescribers practical tools to help patients overcome those barriers and stay on therapy.

Why Jublia Access Is Different from Most Prescriptions

Jublia is a brand-name specialty topical with no widely available generic as of 2026. At retail, it costs roughly $923–$1,055 per 4 mL bottle. Treatment lasts 48 weeks, requiring up to 12 or more refills. Most commercial insurance plans either exclude it from formulary, require step therapy, or place it on a high-cost tier with significant patient cost-sharing. Medicare Part D typically doesn't cover it at all.

This means that without proactive counseling and access support at the point of prescribing, a substantial portion of your patients will abandon treatment before it begins — or within the first few months.

Step 1: Check Insurance Coverage Before Writing the Prescription

Use your practice's EHR formulary checker or call the patient's plan to determine:

Is Jublia on the formulary? At what tier?

Is prior authorization required?

Is step therapy required? What alternatives must be tried first?

Is the patient on Medicare or Medicaid? (Both significantly limit Jublia access)

For patients on Medicare or Medicaid, or those with plans that don't cover Jublia, have an alternative plan ready before they leave the office.

Step 2: Direct Patients to the Right Pharmacy

The manufacturer savings program (Rx Access Program) is only valid at Walgreens and participating independent pharmacies. Sending the prescription to a CVS, Rite Aid, or Walmart pharmacy will lock the patient out of the best savings option.

If your patient is cash-pay or uninsured, specifically route the prescription to a Walgreens location or a participating independent that is enrolled in the Rx Access Program. You can point patients to OrthoRxAccess.com to verify pharmacy eligibility before filling.

Step 3: Provide a Prior Authorization Letter or Supporting Documentation

If your patient has insurance that requires prior authorization, being proactive at the time of prescribing can save days or weeks of delay. Prepare documentation that includes:

Lab-confirmed diagnosis of onychomycosis (KOH prep + culture, PAS stain, or PCR)

Clinical rationale for topical over oral therapy

Contraindications or intolerances to oral terbinafine (hepatic disease, drug interactions, prior side effects)

History of prior treatment failure or inadequate response to alternatives

Submit the PA request alongside the prescription to minimize wait time. Most PA decisions for Jublia are made within 3–7 business days.

Step 4: Counsel Patients on Savings Options at the Point of Care

Many patients don't know about manufacturer savings programs or discount card services. A brief mention at the end of the visit — or a handout prepared by your front desk — can dramatically improve prescription fill rates. Key programs to mention:

Ortho Dermatologics Rx Access Program: OrthoRxAccess.com. $0 for commercially insured patients with coverage; $75/bottle cash-pay. Walgreens and participating independents only.

Bausch Health Patient Assistance Program: For eligible low-income uninsured patients. May provide Jublia at no cost.

GoodRx / SingleCare: Available at most chain pharmacies; reduces price to ~$727–$741 per 4 mL bottle.

Step 5: Write the Prescription for a 90-Day Supply When Appropriate

Since treatment lasts 48 weeks, writing a prescription for a 90-day supply (where clinically appropriate and allowed by the plan) can reduce the frequency of pharmacy visits and, in some cases, lower the per-unit cost. Some mail-order plans also offer lower copays for larger quantities. Note: a 30-day quantity prescription will not allow 90-day fills, so specify the 90-day quantity explicitly.

Step 6: Have an Alternative Ready

If Jublia is truly inaccessible for your patient, have a first alternative ready. For most patients, oral terbinafine (generic Lamisil) is the preferred clinical alternative — far more effective than any topical option, and generic terbinafine tablets cost as little as $10–$20 for the full 12-week course with a GoodRx coupon. For patients who truly need topical-only treatment, consider generic ciclopirox nail lacquer as the most affordable option.

How medfinder Can Help Your Patients

For patients struggling to find a pharmacy that has Jublia in stock and participates in savings programs, recommend medfinder. medfinder calls pharmacies near the patient to find which ones can fill their prescription, and texts the results directly to the patient. It removes the friction of calling multiple pharmacies — a real barrier to treatment adherence for long-course therapies like Jublia.